Juliane Katja Vierecke , MD
Associate Professor of Clinical
Medical Sciences Building
COM IM Cardiology B - 0542
Education
Undergraduate Degree: Bertolt Brecht Gymnasium Brandenburg, Germany, 2000
Medical Degree: Berlin University School of Medicine Germany, 2006
Residency, Internal Medicine: University School of Medicine Switzerland, 2008
Fellowship, Cardiovascular Diseases: German Heart Institute Germany, 2012 (Heart Failure & Mechanical Circulatory Support)
Clinical Interests
Cardiology
Cardiovascular Disease
Heart Failure
Heart Transplant
Specialities
Heart Failure/Transplant
Research Support
Investigators:Vierecke, Juliane -11-30-2024 Merck Sharp & Dohme Corp A Pivotal Phase 3 Randomized, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of the sGC Stimulator Vericiguat/MK-1242 in Adults W/Chronic HF With Reduced Ejection Fraction Role:PI 0.00 Hold Level:Industry
Grant: #BalanceDHF Investigators:Vierecke, Juliane 03-01-2024 -03-01-2028 AstraZeneca Pharmaceuticals LP BalanceD HF: A Phase III, Randomized, Double-blind Study to Evaluate the Effect of Balcinrenone/Dapagliflozin, Compared with Dapagliflozin, on the Risk of Heart Failure Events Role:PI 342622.21 Hold Level:Industry